Publications

Life Saving Drugs Program – MPS I – Review summary and expert panel recommendations for consumers

This MPS I review considered laronidase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

Life Saving Drugs Program – MPS I – Medicines review summary for consumers

About this resource

Publication date:
Publication type:
Procedure
Audience:
General public
Language:
English
Part of a collection:
Life Saving Drugs Program resources – Mucopolysaccharidosis type I (MPS I)
Tags: 

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.